Picard Medical, Inc. PMI
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 38.62% | 85.48% | 20.69% | 34.73% | 207.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.62% | 85.48% | 20.69% | 34.73% | 207.06% |
| Cost of Revenue | 3.54% | -10.53% | -14.57% | -15.25% | 109.85% |
| Gross Profit | 585.04% | 176.82% | 202.21% | 80.68% | 66.75% |
| SG&A Expenses | 46.02% | 38.99% | -1.78% | -14.38% | 5.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.16% | 46.43% | -8.98% | -12.23% | 25.10% |
| Operating Income | -31.47% | -38.97% | 15.93% | 21.53% | 7.92% |
| Income Before Tax | 15.93% | -37.72% | 51.58% | -68.00% | -65.74% |
| Income Tax Expenses | -- | -- | 126.67% | -- | -- |
| Earnings from Continuing Operations | 15.82% | -36.95% | 51.45% | -68.00% | -65.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.82% | -36.95% | 51.45% | -68.00% | -65.74% |
| EBIT | -31.47% | -38.97% | 15.93% | 21.53% | 7.92% |
| EBITDA | -31.69% | -39.36% | 16.06% | 21.72% | 8.97% |
| EPS Basic | 92.81% | 87.15% | 95.14% | 77.92% | -39.86% |
| Normalized Basic EPS | 92.59% | 91.26% | 93.54% | 75.49% | -45.53% |
| EPS Diluted | 92.81% | 87.15% | 95.14% | 77.92% | -39.86% |
| Normalized Diluted EPS | 92.59% | 91.26% | 93.54% | 75.49% | -45.53% |
| Average Basic Shares Outstanding | 946.11% | 834.77% | 827.77% | 585.48% | -97.81% |
| Average Diluted Shares Outstanding | 946.11% | 834.77% | 827.77% | 585.48% | -97.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |